In the current study, gastric cancer cells were then treated with rhodium(III) complex 6 (RHD6) [14], a novel STAT3 inhibitor, to determine whether the suppression of STAT3 would derepress GATA6 and TFF1/2. The gene discussed is GATA6; the disease is gastric cancer.